PNPL:OTC-Pineapple Express (USD)

COMMON STOCK | Pharmaceutical Retailers |

Last Closing

USD 0.22

Change

0.00 (0.00)%

Market Cap

USD 0.01B

Volume

N/A

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Pineapple, Inc. operates as a portfolio management company in the cannabis sector. The company procures and leases properties to licensed cannabis operators; and provides hemp-derived CBD sales via online and in-store transactions. It also offers cannabis business licensing and consulting services. The company was founded in 1983 and is headquartered in Los Angeles, California.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-11-13 )

Largest Industry Peers for Pharmaceutical Retailers

Symbol Name Price(Change) Market Cap
JDHIY JD Health International Inc

N/A

USD 12.16B
JDHIF JD Health International Inc

N/A

USD 9.97B
ALBHF Alibaba Health Information Tec..

N/A

USD 8.27B
RADLY Raia Drogasil SA ADR

-0.29 (-5.87%)

USD 7.74B
CLCGY Clicks Group Ltd

+0.63 (+1.50%)

USD 5.11B
SHPPF Shop Apotheke Europe N.V

N/A

USD 3.23B
SAEYY Shop Apotheke Europe N.V

N/A

USD 3.16B
NOTR Nowtransit Inc

N/A

USD 0.55B
ZRSEF Zur Rose Group AG

-3.47 (-8.17%)

USD 0.54B
NVACF Nova Cannabis Inc

N/A

USD 0.08B

ETFs Containing PNPL

N/A

Market Performance

  Market Performance vs. Industry/Classification (Pharmaceutical Retailers) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 23.60% 71% C- 70% C-
Dividend Return N/A N/A N/A N/A N/A
Total Return 23.60% 71% C- 70% C-
Trailing 12 Months  
Capital Gain 83.33% 76% C+ 83% B
Dividend Return N/A N/A N/A N/A N/A
Total Return 83.33% 76% C+ 83% B
Trailing 5 Years  
Capital Gain -56.00% 71% C- 34% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -56.00% 71% C- 35% F
Average Annual (5 Year Horizon)  
Capital Gain 574.60% 92% A 93% A
Dividend Return 574.60% 92% A 93% A
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 1,975.52% 8% B- 8% B-
Risk Adjusted Return 29.09% 80% B- 64% D
Market Capitalization 0.01B 52% F 40% F

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

What to not like:
Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.

Negative free cash flow

The company had negative total free cash flow in the most recent four quarters.